tradingkey.logo
tradingkey.logo
Suchen

Rxsight Inc

RXST
Zur Watchlist hinzufügen
5.610USD
+0.440+8.51%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
232.23MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Rxsight Inc Unternehmen

RxSight, Inc. is a commercial-stage medical technology company dedicated to providing customized vision to patients following cataract surgery. The Company's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.

Rxsight Inc Informationen

BörsenkürzelRXST
Name des UnternehmensRxsight Inc
IPO-datumJul 30, 2021
CEOKurtz (Ron M)
Anzahl der mitarbeiter498
WertpapierartOrdinary Share
GeschäftsjahresendeJul 30
Addresse100 Columbia Street
StadtALISO VIEJO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92656
Telefon19495217822
Websitehttps://www.rxsight.com/
BörsenkürzelRXST
IPO-datumJul 30, 2021
CEOKurtz (Ron M)

Führungskräfte von Rxsight Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Robert K. Warner
Mr. Robert K. Warner
Independent Director
Independent Director
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
497.92K
+0.33%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
96.14K
+38.52%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
79.55K
+15.70%
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
78.08K
+47.44%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
55.17K
+67.13%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
39.45K
+2.79%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Rxsight Inc?

Die fünf größten Anteilseigner von Rxsight Inc sind: Mr. Eric Weinberg

Wie viele Institutionen halten Anteile an Rxsight Inc (RXST)?

Mit Stand vom 2026Q1 halten 467 Institutionen Anteile an Rxsight Inc, mit einem Gesamtmarktwert von etwa 38.60M, was 93.24% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -10991579.00 gestiegen.